Evidence map›Paper›PMID 42177738›Full record

ArticleHuman cell2026

NOTCH3 signal activation by its extracellular domain accumulation in an iPSC line newly established from a CADASIL patient.

Ruihua Sun, Zhenxiang Zhao, Ningning Che, Ning Liu, Xiaoyi Ji, Anqi Li, Fengyu Wang, Junkui Shang, Jiewen Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruihua Sun *Department of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China.
Zhenxiang Zhao *Department of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China.
Ningning Che *Department of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China.
Ning LiuDepartment of Neurology, Nanyang Central Hospital, Nanyang, 473000, Henan, China.
Xiaoyi JiDepartment of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China.
Anqi LiDepartment of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China.
Fengyu WangDepartment of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China. wangfengyu1979@163.com.
Junkui ShangDepartment of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China. shangjunkui@yeah.net.
Jiewen ZhangDepartment of Neurology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China. zhangjiewen9900@126.com.

Funding

the Henan Provincial Key Research and Development Special Program 241111313500the Henan Provincial Major Project of Medical Science and Technology Key Research Program under Provincial-Ministerial Co-Construction SBGJ202401002the National Natural Science Foundation of China 82171196the Natural Science Foundation of Henan Province 262300420560
6 · The paper itself

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic cerebral small-vessel disease caused by NOTCH3 mutations, yet its pathogenic mechanisms remain incompletely understood due to limited disease models. The NOTCH3 R544C mutation is a prevalent hotspot in East Asian populations, but patient-derived iPSC models are lacking. Here, we generated an iPSC line from peripheral blood mononuclear cells of a middle-aged CADASIL patient carrying a heterozygous NOTCH3 c.1630C > T (p.Arg544Cys, R544C) mutation using a Sendai virus (SeV)-based reprogramming approach. The iPSCs exhibited typical morphology, normal 46, XY karyotype, expressed pluripotency markers (OCT4, NANOG, TRA-1-60, SSEA-4), and cleared SeV vectors after passaging. They differentiated into derivatives of all three germ layers, and STR analysis confirmed donor identity. Functionally, CADASIL iPSCs showed abnormal accumulation of the NOTCH3 extracellular domain (NOTCH3ECD) with unchanged NOTCH3 full-length and intracellular domain levels, and upregulation of canonical downstream genes HEY1, NRARP, and HES1, indicating activation of the NOTCH3 signaling pathway. This study establishes and characterizes a NOTCH3 R544C patient-derived iPSC line, providing a valuable model for investigating CADASIL pathogenesis and potential therapeutic strategies, with novel insights into early NOTCH3ECD accumulation and pathway activation.

Indexed as

CADASILInduced Pluripotent Stem CellsMutationReceptor, Notch3Signal TransductionBasic Helix-Loop-Helix ProteinsCell Cycle ProteinsCell DifferentiationHumansMiddle AgedProtein DomainsSendai virusTranscription Factor HES-1Basic Helix-Loop-Helix ProteinsCell Cycle ProteinsHES1 protein, humanHEY1 protein, humanNOTCH3 protein, humanReceptor, Notch3Transcription Factor HES-1CADASILDisease modelInduced pluripotent stem cellsNOTCH3R544C mutation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.